LG.CVDRisk
Biomarker1 paper3 findings
- Humans1
Effects
2Cardiovascular risk stratification
upin humans1
1 study
Cardiovascular risk stratification
upin humans1
LG.CVDRisk improves cardiovascular risk stratification in humans (NRI 0.305, 95% CI 0.212-0.397).
Humansin the intermediate-risk groupn = 13,521
Integration of lipidomic and polygenic risk scores within contemporary clinical cardiovascular risk assessment pathways: a multi-cohort development and validation study · EClinicalMedicine · 24 Aug 2026
Discrimination
upin humans1
1 study
Discrimination
upin humans1
LG.CVDRisk improves discrimination in humans (ΔC 0.071, 95% CI 0.033-0.109).
Humansamong intermediate-risk individualsn = 13,521
Integration of lipidomic and polygenic risk scores within contemporary clinical cardiovascular risk assessment pathways: a multi-cohort development and validation study · EClinicalMedicine · 24 Aug 2026
Associations
1Cardiovascular disease risk
upin humans1
1 study
Cardiovascular disease risk
upin humans1
LG.CVDRisk predicts cardiovascular disease risk in humans (17 (41%) of 41).
Humansin intermediate-risk individuals with extensive coronary calcificationn = 41
Integration of lipidomic and polygenic risk scores within contemporary clinical cardiovascular risk assessment pathways: a multi-cohort development and validation study · EClinicalMedicine · 24 Aug 2026